calypsol 50 mg/ml solution for injection
gedeon richter plc. - Кетаминът - 50 mg/ml solution for injection
coagadex
bpl bioproducts laboratory gmbh - Човешкия фактор за съсирването на х - Фактор x недостатъчност - vitamin k and other hemostatics, antihemorrhagics, coagulation factor x - coagadex е показан за лечение и профилактика на епизоди на кървене и за периоперативно лечение при пациенти с дефицит на наследствен фактор Х. coagadex се посочва във всички възрастови групи.
benfogamma 50 mg coated tablets
worwag pharma gmbh & co. kg - Бенфотиамин - 50 mg coated tablets
milgamma 100 100 mg/100 mg coated tablets
worwag pharma gmbh & co. kg - Бенфотиамин, Пиридоксин - 100 mg/100 mg coated tablets
milgamma na injekt 100 mg/50 mg/ml solution for injection
woerwag pharma gmbh & co. kg - Тиамин, Пиридоксин - 100 mg/50 mg/ml solution for injection
milgamma protect 300 mg film - coated tablets
woerwag pharma gmbh & co. kg - Бенфотиамин - 300 mg film - coated tablets
introvit b complex
interchemie werken de adelaar b.v. - Тиамин хидрохлорид, рибофлавин фосфат натрий, пиридоксин хидрохлорид, цианокобаламин, Декспантенол, никотинамид, биотин, холин хлорид - инжекционен разтвор - 10 mg/ml; 5 mg/ml; 5 mg/ml; 20 µg/ml; 12,5 mg/ml; 50 mg/ml; 100 µg/ml; 10 mg/ml - говеда, кози, коне, овце, свине
vitacen k3 100 mg/ml
cenavisa s.l. - Витамин К3 (Менадион bisulfate натрий) - инжекционен разтвор - 100 mg/ml - говеда, кози, коне, котки, кучета, овце, свине
clopidogrel viatris (previously clopidogrel taw pharma)
viatris limited - клопидогрел безилат - peripheral vascular diseases; stroke; myocardial infarction - Антитромботични агенти - secondary prevention of atherothrombotic events clopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. adult patients suffering from acute coronary syndrome. non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). Възхода на сегмента st остър инфаркт на миокарда, в комбинация с ВЪЗХОДЯЩО в лечението на пациенти, които имат право на тромболитической терапия. in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is) clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. prevention of atherothrombotic and thromboembolic events in atrial fibrillation:in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. За повече информация, моля, вижте раздел 5.